Tyler Moyer
Senior Scientist I, Novel Capsid Discovery at Voyager Therapeutics, Inc. | Boston, Massachusetts, United States
Tyler Moyer’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Senior Scientist I, Novel Capsid Discovery at Voyager Therapeutics, Inc. in January 2023 - Present
Scientist II, Novel Capsid Discovery at Voyager Therapeutics, Inc. in July 2021 - December 2022
Scientist I, Novel Capsid Discovery at Voyager Therapeutics, Inc. in June 2019 - June 2021
The Johns Hopkins University School of Medicine, January 2013 to January 2019
Bucknell University, January 2007 to January 2011
Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; and Neurocrine Biosciences, Inc. For more information, visit www.voyagertherapeutics.com. Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc.
Discover more about Voyager Therapeutics, Inc.Sr. Executive Assistant at Voyager Therapeutics, Inc.
Sr. Executive Assistant at Voyager Therapeutics, Inc.
(May 2018 – Present)
Senior Scientist | Biophysics & Analytical Chemistry Expert | Mass Spectrometry, Chromatography & Protein Characterization Specialist
Senior Scientist at Voyager Therapeutics, Inc.
(Sep 2025 – Present)
Chief Medical Officer @ Voyager Therapeutics |
Chief Medical Officer at Voyager Therapeutics, Inc.
(Mar 2024 – Present)
In-Vivo Scientist | Gene Therapy & Neuroscience | Huntington’s Disease | AAV, Rodent Models| Voyager Therapeutics
Promoted to lead expanded in-vivo research responsibilities for gene therapy programs targeting neurodegenerative diseases.
- Leading CNS gene therapy studies from study design through execution and analysis, supporting IND-enabling work
- Driving cross-functional collaborati...
Senior Director, Corporate and Business Development at Voyager Therapeutics
Senior Director, Corporate and Business Development at Voyager Therapeutics, Inc.
(May 2025 – Present)
Head of Data Science and Payload Innovation
Leading the machine learning, bioinformatics, and payload engineering teams to advance next-generation gene and protein platform technologies (AAV capsids and antibodies).
Building biological platform tools including regulatable expression systems, tissue-specific promoters, ...
What is Tyler Moyer email address?
Email Tyler Moyer at [email protected]. This email is the most updated Tyler Moyer's email found in 2026.
How to contact Tyler Moyer?
To contact Tyler Moyer send an email to [email protected].
What company does Tyler Moyer work for?
Tyler Moyer works for Voyager Therapeutics, Inc..
What is Tyler Moyer's role at Voyager Therapeutics, Inc.?
Tyler Moyer is Senior Scientist I, Novel Capsid Discovery
What industry does Tyler Moyer work in?
Tyler Moyer works in the Biotechnology industry.